Clinical trial

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

NCT07691697

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-06-26

PhaseN/A

Study timeline

Study start (actual)2026-06-26Date precision: day

Registry last updated2026-09-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Oligoprogressive Prostate Cancerunresolved

Metastatic Prostate Cancerunresolved

Interventions

Comprehensive Progression-Directed RadiotherapyRADIATION

Sponsors & collaborators

Affidea Nu-med Center of Oncological DIagnostics and Therapylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07691697 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.